A study has found that the psychedelic drug MDMA, combined with talk therapy, can reduce symptoms of post-traumatic stress disorder.

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.

  • treefrog@lemm.ee
    31·
    1 年前

    Not really.

    A drug war that criminalized medicine that Dr’s where researching and that people were enjoying for both personal exploration and recreation is the opposite end of the spectrum.